SPY301.43-1.54 -0.51%
DIA252.72-1.63 -0.64%
IXIC9,357.83-11.16 -0.12%

Intra-Cellular Therapies Q1 EPS $(0.730) Beats $(0.930) Estimate, Sales $1.083M Miss $1.440M Estimate

Intra-Cellular Therapies (NASDAQ:ITCI) reported quarterly losses of $(0.730) per share which beat the analyst consensus estimate of $(0.930) by 21.51 percent. This is a 15.87 percent decrease over losses of $(0.630) per

Benzinga · 05/07/2020 12:12

Intra-Cellular Therapies (NASDAQ:ITCI) reported quarterly losses of $(0.730) per share which beat the analyst consensus estimate of $(0.930) by 21.51 percent. This is a 15.87 percent decrease over losses of $(0.630) per share from the same period last year. The company reported quarterly sales of $1.083 million which missed the analyst consensus estimate of $1.440 million by 24.79 percent.